Brensocatib Aspen Trial Results in NEJM!

This diagram — “Neutrophils: Defender and Offender” — is what Dr. Chalmers often refers to as a “confusagram” (I think that’s the word he uses!).

Does anyone remember Highlights magazine, where you had to find hidden objects — like a hammer tucked inside a tree?
That’s exactly what this feels like!

Can you spot the word brensocatib hidden in the diagram?

Many of us have been following the development of brensocatib for years, from the Phase 2 WILLOW trial to the Phase 3 ASPEN trial.

Although the results were shared publicly last year and discussed extensively at the Bronchiectasis World Conference in Dundee, Scotland, the findings have now been formally published in The New England Journal of Medicine, one of the most prestigious medical journals in the world.

I knew the article was coming, as I’ve heard Dr. Chuck Daley reference it multiple times. How exciting — for him, for the bronchiectasis community, and for all of us living with the heavy burden of this disease and desperately needing relief.

So, as I always say, let’s continue to stay the course: keep our weight in a healthy zone, eat nutrient-dense foods, do our airway clearance, exercise, control GERD, and just as importantly, try to have faith and relax — knowing that help is on the way!

Happy weekend,
Linda Esposito